WVE Q3 2023 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$49M+17168.1% YoY

Gross Profit

$18M35.7% margin

Operating Income

$4M9.0% margin

Net Income

$7M14.7% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+122.6%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$35M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$200M

Total Liabilities

$240M

Stockholders' Equity

-$40M

Cash & Equivalents

$140M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49M	$285,000	+17168.1%
Gross Profit	$18M	-$27M	+164.4%
Operating Income	$4M	-$39M	+111.4%
Net Income	$7M	-$39M	+118.6%